Leading pediatric endocrinologist and recipient of the Endocrine Society’s 2025 Outstanding Leadership in Endocrinology Laureate Award, Ilene Fennoy, MD, talks with Endocrine News about the potential of GLP-1s and long-term solutions for childhood obesity. She says a good place to start is creating more programs in schools to help kids eat better and incorporate more...
An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Celltrion Receives U.S. FDA Approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) Biosimilars Referencing PROLIA® and XGEVA® On March 3, Celltrion announced that the U.S. Food and Drug Administration (FDA) has approved STOBOCLO® (CT-P41, denosumab-bmwo) and OSENVELT® (CT-P41, denosumab-bmwo), biosimilars referencing PROLIA® (denosumab) and XGEVA® (denosumab) respectively...
Endocrine News speaks to the participants of the ENDO 2025 symposium “Future Developments and Challenges in Obesity Treatment: Where Will We Stand at ENDO 2030?” who discuss the future of treating this formidable condition. This July, the year’s biggest event in endocrinology happens in San Francisco, Calif. Although every ENDO is special, ENDO 2025...
As February gets underway, Endocrine News is taking this opportunity to commemorate Black History Month with a roundtable that features some of the Endocrine Society’s outstanding Black members who have made remarkable contributions to not only the Society, but to the field of endocrinology (“Lift Every Voice”). These five members were very generous with their...
Fatima Cody Stanford, MD, MPH, MPA, MBA, takes the lessons she learned growing up in Atlanta serving her community and applies them to her work treating obesity. In July, she’ll give the plenary presentation at ENDO 2025, “Changing the Game of Obesity Care Across Lifespan: Policies, Diets, and Drug Innovation,” offering attendees a comprehensive overview...
Endocrine Society member Tina Gupta, MD, spent many years managing her patients’ type 1 diabetes when she was in a clinical setting. Now that she’s associate medical director on the Type 1 Diabetes Medical Affairs team at Vertex Pharmaceuticals, she’s even more determined to help find solutions to help these patients. As an endocrinologist, my...
On behalf of the Endocrine Society’s Early-Career Special Interest Group (SIG), Milay Luis Lam, MD, shares her early-career journey from Peru to the U.S., and what she learned every step of the way. Read why it’s important for the next generation of endocrinologists – both physicians and scientists – to be aware of the varied...
Hormones may be leveraged to treat and prevent signs of aging such as wrinkles and hair graying, according to a new study published in the Endocrine Society journal Endocrine Reviews. Until now, only a limited number of hormones, mainly topical retinoids (retinol and tretinoin) and estrogen which is typically used to treat side effects of menopause,...
Endocrine News speaks to the participants of the ENDO 2025 symposium “Future Developments and Challenges in Obesity Treatment: Where Will We Stand at ENDO 2030?” who discuss the future of treating this formidable condition. This July, the year’s biggest event in endocrinology happens in San Francisco, Calif. Although every ENDO is special, ENDO 2025...
As February gets underway, Endocrine News is taking this opportunity to commemorate Black History Month with a roundtable that features some of the Endocrine Society’s outstanding Black members who have made remarkable contributions to not only the Society, but to the field of endocrinology (“Lift Every Voice”). These five members were very generous with their...
